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Abstract
Background Conformal sphincter preservation operation (CSPO) is a new surgical procedure for very low rectal cancers 
(within 4–5 cm from the anal verge). CSPO preserves more of the dentate line and distal rectal wall and also avoids injur-
ing nerves in the intersphincteric space, resulting in satisfactory anal function after resection. The aim of this study was to 
analyze the short-term surgical results and long-term oncological and functional outcomes of CSPO.
Methods Consecutive patients with very low rectal cancer, who had CSPO between January 2011 and October 2018 at 
Changhai Hospital, Shanghai were included. Patient demographics, clinicopathological features, oncological outcomes and 
anal function were analyzed.
Results A total of 102 patients (67 men) with a mean age of 56.9 ± 10.8 years were included. The median distance of the 
tumor from the anal verge was 3 (IQR, 3–4) cm. Thirty-five patients received neoadjuvant chemoradiation (nCRT). The 
median distal resection margin (DRM) was 0.5 (IQR, 0.3–0.8) cm. One patient had a positive DRM. All circumferential 
margins were negative. There was no perioperative mortality. The postoperative complication rate was 19.6%. The median 
duration of follow-up was 28 (IQR, 12–45.5) months. The local recurrence rate was 2% and distant metastasis rate was 10.8%. 
The 3-year overall survival and disease-free survival rates were 100% and 83.9%, respectively. The mean Wexner incontinence 
and low anterior resection syndrome scores 12 months after ileostomy reversal were 5.9 ± 4.3, and 29.2 ± 6.9, respectively.
Conclusions For patients with very low rectal cancers, fecal continence can be preserved with CSPO without compromising 
oncological results.
Keywords Rectal neoplasms · Surgery · Disease-free survival · Postoperative complications · Margins of excision · 
Follow-up studies · Neoplasm recurrence · Local · Low anterior resection syndrome
Introduction
Very low rectal cancer within 4–5 cm from the anal verge 
has traditionally been treated by abdominoperineal resection 
(APR) with acceptable oncological results [1, 2]. However, 
a permanent stoma decreases patients’ quality of life signifi-
cantly [3]. With the advancement of surgical oncology and 
instrumentation, intersphincteric resection (ISR) and coloa-
nal anastomosis (CAA) have gained widespread acceptance. 
The reduction of the distal resection margin did not seem to 
impact the incidence of recurrence and long-term survival 
[4]. However, according to the literature and our experience 
with ISR, patients often have poor anal function after sur-
gery due to removal of the internal anal sphincter and the 
dentate line, which are important parts of the anal sphincter 
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complex [5, 6] and also because of the extensive dissection 
in the intersphincteric space (ISS) which destroys autonomic 
nerves [7, 8]. The functional problems after ISR lead to a 
significant decrease in postoperative quality of life [9, 10]. 
To overcome this functional shortcoming, we designed a 
new surgical procedure, the conformal sphincter preserva-
tion operation (CSPO). CSPO preserves more dentate line 
and distal rectal wall and also avoids injuring nerves in the 
intersphincteric space. Besides, the anastomosis is fashioned 
on the part with more preserved rectal wall, thus the anas-
tomosis ring can be 2–3 cm above the dentate line so as 
to get more satisfactory anal function after resection. The 
initial experiences of this procedure have already been pub-
lished [5]. The aim of the present study was to analyze the 
short-term surgical results and long-term oncological and 
functional outcomes of CSPO.
Materials and methods
Patient selection
This retrospective study was conducted in the Department 
of Colorectal Surgery, Changhai Hospital, Shanghai, China. 
All procedures were performed in accordance with the ethi-
cal standards of our institutional research committee and 
with the 1964 Helsinki Declaration and its later amendments 
or comparable ethical standards. The demographic, clinico-
pathological and follow-up information were recorded in our 
Colorectal Cancer Database. All patients who had CSPO 
performed by the same surgical team between January 2011 
and October 2018 were reviewed. Patients who met all of the 
following criteria were included into the study: (1) proven 
rectal adenocarcinoma with digital rectal examination, 
colonoscopy and biopsy; (2) the tumor did not infiltrate the 
intersphincteric space; (3) neoadjuvant therapy in the case 
of preoperative stage T3–T4 or N+ , or if the circumferen-
tial margin was considered positive; (4) good anal function 
before the operation; (5) the distance from the inferior tumor 
edge to the anal verge was less than 4–5 cm on rectal digital 
examination; or less than 2 cm from the dentate line on proc-
toscopy or colonoscopy; (6) the diameter of the tumor was 
less than 3 cm and occupied less than 1/3 circumference of 
the lumen (the actual diameter measured after resection may 
be slightly larger). Exclusion criteria were: (1) distant metas-
tasis including those with metastatic lymph nodes outside 
of mesorectum; (2) poorly differentiated or undifferentiated 
cancers; (3) patient unable to tolerate the operation (Ameri-
can Society of Anesthesiologists (ASA) class > 3).
Surgical technique
The CSPO starts with standard mobilization of the sigmoid 
colon, ligation of the inferior mesenteric artery at its origin 
and mobilization of the rectum according to the principle 
of total mesorectal excision (TME) with attention paid to 
preserve the autonomic nerves. Dissection of the rectum 
continues downward until reaching the hiatal ligament [11]. 
After cutting the hiatal ligament (Fig. 1), dissection stops 
at the entrance of the intersphincteric space, which is one 
of the main differences between ISR and CSPO (Fig. 2). 
The rectum is transected at the rectosigmoid junction. Sub-
sequently, the anus is dilated to 3–4 fingers wide and the 
rectum was pulled out of the anus through the rectal lumen 
(Fig. 1). The conformal incision line is designed accord-
ing to the tumor’s location and size. The key point of this 
procedure is to preserve as much of the lower rectum, den-
tate line and internal anal sphincter, on the side opposite to 
the tumor as possible. The intersphincteric space was left 
undisturbed to prevent injuring the numerous nerve fibres 
it contains [7] to preserve the function of the remaining 
internal sphincter. The distal dissection line is made at least 
1 cm below the inferior tumor margin under direct vision. In 
cases where the tumor cannot be inverted from the rectum, 
in-situ transanal excision can still be performed to preserve 
adequate rectal wall appropriately. The remnant rectal stump 
was then closed with interrupted sutures. Intraoperative 
frozen-section examination was performed in all cases to 
ensure an adequate oncological DRM. Following the rectal 
stump closure, a 25 mm circular stapler (CDH25, Johnson 
& Johnson, USA) was used to perform the anastomosis [12] 
(Fig. 1). The stapler is inserted as high in the rectal stump 
as possible, to make the anastomosis as high as possible on 
the opposite side. Consequently, as much as possible of the 
dentate line and internal anal sphincter are preserved on the 
opposite side. Temporary ileostomy was routinely performed 
in all patients. The anastomotic line is shown in Fig. 3: it 
is 2–3 cm above the dentate line even though the patient 
has such a low rectal cancer. Patients with pathological 
stage III or stage II disease with high-risk features received 
postoperative Capeox or mFOLFOX6 regimen as adjuvant 
chemotherapy. Postoperative radiotherapy was performed in 
patients who had not had preoperative radiotherapy accord-
ing to the following criteria: (1) pathological result ≥ N1b 
or circumferential resection margin (CRM) positive; (2) T3 
or T4; (3) distal margin too short (usually less than 0.3 cm).
Ileostomy reversal
The ileostomy was closed 3–6 months after the resec-
tion or after finishing adjuvant chemical or chemo-radio 
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therapy, depending on the clinical fitness of the patient and 
the following criteria: (1) the digital rectal examination 
was performed every 4 weeks after the resection to make 
sure the anastomotic ring was smooth, complete and no 
stenosis; (2) local recurrence excluded by pelvic magnetic 
resonance imaging (MRI), a chest computed tomography 
(CT) scan and MRI of liver excluded distant metastases; 
(3) defecography with iodized water was performed when 
there was any suspicion of an anastomotic leakage; (4) 
colonoscopy was performed to make sure that there was no 
stenosis and local recurrence at the anastomosis and that 
the anastomotic line was complete and with no obstruction 
in the proximal bowel.
Oncological and functional follow‑up
Patients were followed every 3 months for the first 2 years, 
every 6 months for the next 3 years, and once a year there-
after. Digital rectal examination, carcinoembryonic antigen 
and carbohydrate antigen 19-9 test were performed at every 
follow-up visit; chest CT scan, MRI of the liver and pelvis 
with intravenous contrast and colonoscopy was performed 
Fig. 1  The CSPO technique. a, b The tumor was pulled out of the 
anus through the rectal lumen, the distal dissection line was made at 
least 1 cm below the inferior tumor margin, preserving more rectum 
on the opposite tumor side. c The rectal stump was closed by manual 
interrupted sutures. d The stapler was inserted to the upper tip of the 
rectal stump to preserve more rectum wall. e, f The hiatal ligament
Fig. 2  Drawing of the transection lines for ISR (blue lines). Total 
intersphincteric resection (total-ISR) is defined as an internal sphinc-
ter resection at the intersphincteric groove, subtotal-ISR is between 
the dentate line (DL) and ISG, and partial-ISR is at the DL. But the 
CSPO stops at the entrance of ISS, and resection line in the internal 
sphincter is inclined and conformed to the tumor edge
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according to the National Comprehensive Cancer Network 
(NCCN) guidelines. Postoperative complications were 
graded according to the Clavien–Dindo classification system 
[13]. Anal function was assessed 12 months after ileostomy 
closure using the Wexner fecal incontinence and low anterior 
resection syndrome (LARS) score [14, 15].
Statistical analysis
The continuous variables were reported as mean ± stand-
ard deviation (SD) or as median with interquartile ranges 
(IQR), depending on whether the data were normally dis-
tributed or not. Categorical variables were statistically ana-
lyzed by the Chi-square test and continuous variables were 
compared using Student’s t test or Mann–Whitney test. The 
baseline characteristics and follow-up results were com-
pared between the patients with and without neoadjuvant 
chemoradiotherapy (nCRT). The Kaplan–Meier method 
and log rank test were used for analysis of prognostic fac-
tors for disease-free survival, overall survival and stoma-
free survival. A p value < 0.05 (two sided) was considered 
statistically significant. Statistical analysis was performed 
using IBM SPSS Statistics 23.0 (IBM SPSS Statistics, IBM 
Corporation, Armonk, NY, USA). Figures were generated 




A total of 102 patients (mean age 56.9 ± 10.8 years) met the 
inclusion criteria and had CSPO between January 2011 and 
October 2018. The mean body mass index was 23.0 ± 3.3. 
A total of 35 patients (34.3%) received nCRT followed by 
resection 6–8 weeks after the completion of the neoadjuvant 
therapy. The other 67 patients (65.7%) were treated by sur-
gery without neoadjuvant treatment. Seventeen patients 
(16.7%) received postoperative radiotherapy. The approach 
was by laparoscopy in 38 patients (37.3%), including 1 
(2.6%) conversions to open surgery, and 64 (62.7%) were 
open procedures. The median tumor distance from the anal 
verge was 3 (IQR, 3–4) cm.
The colorectal (or coloanal) anastomoses were performed 
with stapling except in one case when the tumor was too 
low for a stapled anastomosis and a hand-sewn anastomo-
sis was performed. One planned CSPO was converted to 
APR, because two consecutive intraoperative frozen-section 
examinations showed tumor cells at the resection margin, 
despite absence of visible tumor. The median DRM was 0.5 
(IQR, 0.3–0.8) cm and all patients had R0 resection and 
negative CRM, except one patient who had a positive DRM 
(< 1 mm). The median number of lymph nodes retrieved 
was 14 (IQR, 10–15.25) and the median tumor diameter 
was 2.7 (IQR, 2–3.5) cm. Complete pathological response 
to neoadjuvant therapy was achieved in 7 of the 35 patients 
who received nCRT (20.0%). Comparing the nCRT and non-
nCRT group, age was significantly lower, the tumor’s largest 
diameter was significantly smaller and cT stage and cN stage 
were more advanced in the nCRT group (Table 1).
Complications
There was no 30-day mortality. The overall complication 
rate was 19.6%. According to the Clavien–Dindo classifi-
cation [13], overall incidence of grade 2 or higher postop-
erative complications was 14.7% (15/102). The details of 
complications in both groups are reported in Table 2.
Oncological results
The median duration of follow-up was 28 (IQR, 
12–35) months. The disease-free survival rates at 1, 2 and 
Fig. 3  Colonoscopy a Preopera-
tive colonoscopy shows that the 
mass is 1 cm above the dentate 
line. b Five months postopera-
tively, colonoscopy shows the 
anastomotic line 2–3 cm away 
from the dentate line
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3 years were 92.5%, 86.3% and 83%, respectively (Fig. 4). 
The 3-year local recurrence-free and distant recurrence-free 
survival rates were 97.5% and 86%, respectively. The local 
recurrence rate was 2% and the distant metastasis rate was 
10.8%.
Ileostomy reversal
The ileostomy was reversed in 79 patients (77.5%; Fig. 5) 
with a median time to reversal of 7 (IQR, 4–10) months. 
The rates of ileostomy reversal in the nCRT and non-nCRT 
groups was 71.4% (25/35) and 80.6% (54/67), respectively, 
however, the difference was not statistically significant 
(p = 0.29). The median time to ileostomy reversal for nCRT 
and non-nCRT patients was 8 (IQR, 5.0–9.5) and 7 (IQR, 
4–10) months, respectively. However, the difference was not 
statistically significant (p = 0.72). The ileostomy-free sur-
vival is shown in Fig. 6.
Functional results
The mean Wexner incontinence and LARS score were 
5.9 ± 4.3, and 29.2 ± 6.9. A total of five patients (11.4%) had no 
LARS (score 0–20), 18 (40.9%) minor LARS (score 21–29), 
Table 1  Baseline characteristics
nCRT neoadjuvant chemoradiotherapy
*Difference between nCRT and non-nCRT group
**Values are reported as mean ± SD or as median and interquartile range
a Distal edge of the tumor to the anal verge
b TNM stage according to AJCC 8th edition
Total (n = 102) nCRT (n = 35) Non-nCRT (n = 67) p*
Age, (years) 56.9 ± 10.8 53.7 ± 9.4 58.5 ± 11.2 0.03
Male sex 67 (65.7%) 20 (57.1%) 47 (70.1%) 0.19
Body mass index (kg/m2) 23.0 ± 3.3 22.3 ± 3.1 23.4 ± 3.3 0.12
Tumor location (cm)a 3 (3–4) 3 (3–4) 3 (3–4) 0.84
Estimated blood loss (ml) 143.3 ± 101.7 147.4 ± 78.0 141.1 ± 112.6 0.77
Laparoscopic surgery 38 (37.3%) 11 (31.4%) 27 (40.3%) 0.38
Operative time (min) 166.9 ± 55.2 171.9 ± 56.5 164.2 ± 54.7 0.51
Postoperative hospital stay (days) 6.8 ± 2.7 6.5 ± 2.3 6.9 ± 2.9 0.41
Distal resection margins (cm) 0.5 (0.3–0.8) 0.5 (0.3–1.0) 0.5 (0.3–0.8) 0.52
Lymph nodes retrieval number 14 (10–15) 10 (5–14) 15 (13–16) < 0.001
Tumor diameter (cm) 2.7 (2–3.5) 2 (1.5–2.5) 3 (2.5–4) < 0.001
cT stage < 0.001
 T1 16 (15.7%) 0 (0%) 16 (23.9%)
 T2 53 (52.0%) 17 (48.6%) 36 (53.7%)
 T3 32 (31.4%) 17 (48.6%) 15 (22.4%)
 T4 1 (1%) 1 (2.9%) 0 (0%)
cN stage 0.001
 N0 55 (53.9%) 11 (31.4%) 44 (65.7%)
 N1–2 47 (46.1%) 24 (68.6%) 23 (34.3%)
pT stage 0.51
 T0 7 (6.9%) 7 (20%) 0 (0%)
 T1 21 (20.6%) 3 (8.6%) 18 (26.9%)
 T2 53 (52.0%) 18 (51.4%) 35 (52.2%)
 T3 21 (20.6%) 7 (20%) 14 (20.9%)
pN stage 0.52
 N0 84 (82.4%) 30 (85.7%) 54 (80.6%)
 N1–2 18 (17.6%) 5 (14.3%) 13 (19.4%)
Pathological stage (TNM)b 0.51
 0 7 (6.9%) 7 (20%) 0
 I 65 (63.7%) 20 (57.1%) 45 (67.2%)
 II 14 (13.7%) 4 (11.4%) 10 (14.9%)
 III 16 (15.7%) 4 (11.4%) 12 (17.9%)
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21 (47.7%) major LARS (score 30–42). The mean Wexner 
score with or without nCRT was 7.1 ± 5.0 and 5.3 ± 4.0, 
respectively (p = 0.15). The mean LARS score with or without 
nCRT was 31.4 ± 6.4 and 28.4 ± 6.9 (p = 0.19). For the post-
operative radiotherapy patients, the mean Wexner score was 
7.3 ± 4.1 (p = 0.92, in comparison to nCRT patients), the mean 
LARS score was 29.6 ± 1.9 (p = 0.47, in comparison to nCRT 
patients), 12 months after ileostomy reversal.
Discussion
The results of our study suggest that CSPO is safe with 
acceptable oncological and functional outcomes and can 
be performed in selected patients with very low, small and 
early-stage rectal cancer. CSPO, therefore, has a role as a 
sphincter saving procedure, with the advantages of achieving 
a balance between oncologic safety and functional results.
With the development of surgical techniques such as 
the pull-through technique, ISR and low anterior resection 
(LAR) with the double stapling method, the rate of sphincter 
preservation in operations for rectal cancer has improved 
[16]. ISR, an anus-preserving technique with internal anal 
sphincter muscle resection, described by Schiessel in 1994 
[17], has become popular around the world [8, 18]. ISR 
for T1–3 tumors located within 30–35 mm from the anal 
verge is technically feasible, safe, and with equal onco-
logical outcomes compared to conventional surgery [19]. 
However, Wexner fecal incontinence scores after ISR were 
significantly higher compared with LAR, thus negatively 
Table 2  Complications after 
CSPO
nCRT neoadjuvant chemoradiotherapy, CSPO conformal sphincter preservation operation
Clavien–Dindo Grade Complication Total (n = 102) nCRT (n = 35) Non-nCRT (n = 67)
Grade ≥ I, n (%) 20 (19.6) 8 (22.9) 12 (17.9)
Grade I, n Wound infection 2 0 2
Bladder retention 1 0 1
Incisional hernia 1 0 1
Inguinal hernia 1 1 0
Grade II, n Urinary infection 1 0 1
Anastomotic leakage 1 0 1
Intestinal obstruction 5 2 3
Radiation proctitis 1 1 0
Rectovaginal fistula 1 0 1
Anastomotic stricture 3 3 0
Pneumonia 1 0 1
Grade IIIa, n Anastomotic leakage 1 1 0
Grade IIIb, n Intestinal obstruction 1 0 1
            a                                                                           b
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Fig. 4  Survival after CSPO. a Disease-free survival, b overall survival
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influencing the postoperative quality of life [20]. According 
to Johannes et al. [21], 80% of the 60 patients’ pathologi-
cal TNM stages were lower than III in ISR, similar to the 
value of 84% in CSPO, while, the mean Wexner score was 
reported to be 10.6 after ISR, higher than 5.9 after CSPO 
in the current study. According to Ahmad Sakr et al. [22], 
70.8% of patients had pathological TNM stages 0 or I after 
ultralow anterior resection, similar to the 70.6% of patients 
treated with CSPO, while the median Wexner incontinence 
score was 10 after ultralow anterior resection, which was 
higher than 5.9 after CSPO seen in our series. This may be 
because more rectal wall, dentate line and anal canal was 
preserved by the conformal resection [23]. For some tumors 
3–4 cm from the anal verge, the anastomotic line can still 
be 2–3 cm above the dentate line in CSPO, which helps 
preserving the anal function. In addition, the nerves in the 
intersphincteric space were left undisturbed as we avoid dis-
section in the intersphincteric space during CSPO.
Kim et al. [24] reported the minimum distance of tumor 
from the anal verge before APR is unavoidable is 3.4 cm, 
compared to 3 cm in the current CSPO group (however, 
with more advanced cancers in the former group). Based on 
the distance from the inferior tumor edge to the anal verge, 
CSPO allowed sphincter preservation in patients who would 
otherwise have had APR, and with acceptable anal function 
after surgery.
The median DRM was just 0.5 cm in the pathologic 
specimens in the current study, but the clinical DRM during 
CSPO was about 1 cm to ensure oncological safety and accu-
rate resection under direct vision. This is consistent with the 
literature [25, 26]. Because of the bowel shrinkage occurring 
during the first 10–20 min after removal from the patients 
and additional shrinkage after formalin fixation, a correction 
factor of 50% reduction in anatomically non-restored fixed 
specimens has been proposed [25, 26]. However, a recent 
systematic review found no negative impact on oncologi-
cal safety when the pathological fixed DRM was < 5 mm in 
a group of patients with favorable tumors [27–29]. Even 
though 78% of DRMs were less than 1 cm in the patho-
logical examination in the current study, the positive DRM 
margin rate was only 0.98% (one patient). In addition to the 
effect of neoadjuvant chemoradiotherapy in 35 patients, this 
probably results from the accurate dissection under direct 
vision during the pull-through part of the CSPO procedure, 
avoiding the difficulty of palpation and locating the tumor 
margin in a narrow pelvis during the abdominal approach, 
especially when encountering the tumor shrinkage after neo-
adjuvant therapy.
Three-year disease-free survival and overall survival after 
CSPO were 83.9% and 100%, respectively. Importantly, 
local recurrence and distant metastasis rates were 2% and 
10.8%, respectively, at a median follow-up of 28 months. 
Actually, the local recurrence rate after rectal sphincter 
preserving surgery combined with radiotherapy has been 
reported to be 4–17% and might be higher after surgery 
without neoadjuvant therapy [30–34]. The reason for these 
lower numbers in the current study might be due to lower 
T and N stage patients in the CSPO group. The complete 
pathological response rate of 20% in nCRT patients is in 
accordance with the complete pathological response rate of 
14–20% reported in the literature [35–38]. The tumor diam-
eter was also relatively smaller after nCRT, which could 
facilitate the pull-through procedure, making the resection 
easier as well as decreasing the squeezing of the tumor dur-
ing the pull-through procedure thus lowering the risk of spill 
of tumor cells and hereby the chance of developing a local 
recurrence.
In the current study, we chose to use the 25 mm cir-
cular stapler rather than a larger size circular stapler to 
Fig. 5  Flow chart of patients
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avoid trauma to the anal canal [39, 40]. Importantly, rectal 
digital examination was performed every month during 
follow-up to prevent anastomotic strictures. The postop-
erative anastomotic stricture rate was acceptable with this 
smaller stapler: the incidence of anastomotic stricture in 
CSPO was 3.9% (three membranous and one fibrotic 
stricture), lower than the corresponding figures of 7.8% 
in ISR reported by Soo Young Lee et al. [41].
Radiotherapy can damage anal function. The Wexner 
incontinence score, LARS score and stoma-free survival 
rate were found to be better in patients without neoadju-
vant radiotherapy in the current study. However, it was 
very interesting to find that there was no significant dif-
ference, as radiotherapy was found to be a risk factor for 
low anterior resection syndrome [42], influence fecal con-
tinence [43] and delay ileostomy reversal [44]. This was 
not a finding in our study, perhaps because we had a study 
population with early rectal cancer and therefore a limited 
part of them received neoadjuvant chemoradiation.
This study has limitations. One limitation is the retro-
spective study design without a control group to compare 
with CSPO. Since we have stopped performing ISR in our 
department due to the disturbed anal function after this 
operation, we do not have a suitable comparison group. 
Another limitation is that the cT and cN stage was differ-
ent between patients with and without nCRT. This also 
shows that CSPO can be a good choice for some early-
stage patients. For some more advanced tumors, CSPO 
can also be an alternative choice to preserve the anus, but 
these patients require nCRT.
Conclusions
CSPO provides an alternative sphincter preserving proce-
dure to treat very low rectal cancer, which is too low to be 
treated by LAR and until now required APR. In addition, 
CSPO using appropriate selection criteria is associated 
with acceptable oncological and functional outcomes, 
especially in patients with a smaller tumor diameter and 
earlier stage rectal cancer. Further comparison with ISR 
is needed.
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non-nCRT     67         66        40        22          6          3
Fig. 6  Stoma free survival of patients after CSPO. a Stoma free survival of all the patients after CSPO. b Stoma free survival for patients with 
and without nCRT, p = 0.23
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